Rifampin-resistant Tuberculosis: Clinical Trials

1 trial for Rifampin-resistant Tuberculosis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 active not recruiting. 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 31Active not recruiting 1

Follow Rifampin-resistant Tuberculosis: new trials by email Literature Review of Rifampin-resistant Tuberculosis trials Research Report on Rifampin-resistant Tuberculosis

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Innovating Shorter, All- Oral, Precised Treatment Regimen for Rifampicin Resistant Tuberculosis:BDLL Chinese Cohort
bedaquiline, delamanid, linezolid - Drug-resistant Tuberculosis, Pulmonary Tuberculosis
Phase 3Active not recruitingHuashan Hospital1202024-11-272025-09-02

Narrower conditions

Tuberculosis, Multidrug-Resistant (1)  ·  Tuberculosis, Pulmonary (1)

Broader conditions

Actinomycetales Infections (1)  ·  Bacterial Infections (1)  ·  Bacterial Infections and Mycoses (1)  ·  Gram-Positive Bacterial Infections (1)  ·  Infections (1)  ·  Lung Diseases (1)  ·  Mycobacterium Infections (1)  ·  Respiratory Tract Diseases (1)  ·  Respiratory Tract Infections (1)  ·  Tuberculosis (1)

Interventions

Clofazimine (1)  ·  Fumigant 93 (1)  ·  Levofloxacin (1)  ·  Linezolid (1)  ·  OPC-67683 (1)  ·  bedaquiline (1)

Sponsors

Huashan Hospital (1)

Countries

China (1)